Pietro Invernizzi Selected Research

Arylalkylamine N-Acetyltransferase

1/2019	Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
10/2017	Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Invernizzi Research Topics

Disease

100	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 07/2003
34	Fibrosis (Cirrhosis) 11/2023 - 06/2005
30	Neoplasms (Cancer) 03/2023 - 08/2004
25	Liver Diseases (Liver Disease) 01/2022 - 10/2007
22	Cholangiocarcinoma 12/2023 - 10/2007
22	Sclerosing Cholangitis 09/2022 - 06/2008
20	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 07/2003
18	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 10/2003
15	Cholestasis 11/2023 - 10/2003
13	COVID-19 11/2023 - 09/2020
13	Autoimmune Hepatitis 10/2023 - 06/2008
12	Inflammation (Inflammations) 01/2020 - 03/2010
10	Disease Progression 01/2022 - 08/2009
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 03/2012
9	Infections 01/2023 - 04/2005
6	Pruritus (Itching) 02/2024 - 06/2008
5	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 11/2010
5	Hyperplasia 01/2020 - 10/2017
4	Cholangitis 03/2013 - 05/2010
3	Genetic Predisposition to Disease (Genetic Predisposition) 10/2023 - 07/2013
3	Liver Failure 01/2023 - 12/2011
3	Liver Neoplasms (Liver Cancer) 09/2022 - 01/2017
2	Esophageal and Gastric Varices (Esophageal Varices) 11/2023 - 01/2018
2	Thrombosis (Thrombus) 11/2023 - 01/2020
2	Adenocarcinoma 03/2023 - 02/2005
2	Fatigue 01/2023 - 01/2023
2	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 10/2020
2	Rheumatoid Arthritis 09/2022 - 01/2015
2	Insulin Resistance 05/2022 - 12/2019
2	Gastrinoma 03/2022 - 09/2021
2	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 03/2022 - 09/2021
2	End Stage Liver Disease 01/2022 - 08/2009
2	Iron Overload 01/2020 - 01/2019
2	Fatty Liver 01/2020 - 04/2011

Drug/Important Bio-Agent (IBA)

24	AutoantibodiesIBA 01/2023 - 08/2005
22	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2023 - 11/2010
20	AntibodiesIBA 10/2023 - 11/2004
16	Alkaline PhosphataseIBA 02/2024 - 04/2011
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2006
12	AntigensIBA 10/2023 - 08/2004
11	Proteins (Proteins, Gene)FDA Link 11/2019 - 11/2004
8	BilirubinIBA 12/2022 - 12/2014
8	EnzymesIBA 09/2020 - 11/2004
7	AutoantigensIBA 01/2023 - 03/2010
7	obeticholic acidIBA 12/2022 - 08/2016
6	CytokinesIBA 10/2023 - 06/2005
6	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 04/2011
6	Immunoglobulin M (IgM)IBA 01/2018 - 04/2005
5	SteroidsIBA 12/2022 - 05/2012
4	Immunoglobulin G (IgG)IBA 02/2024 - 12/2010
4	Hormones (Hormone)IBA 06/2023 - 06/2005
4	AcidsIBA 06/2023 - 11/2010
4	GastrinsIBA 01/2023 - 01/2020
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022 - 02/2016
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 12/2008
4	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2022 - 03/2009
4	Secretin FDA Link 09/2021 - 06/2014
4	Histamine (Histamine Dihydrochloride)FDA Link 12/2019 - 10/2016
4	MicroRNAs (MicroRNA)IBA 12/2016 - 03/2012
4	XenobioticsIBA 12/2012 - 11/2003
3	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 05/2010
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2023 - 02/2005
3	Interleukin-13IBA 10/2023 - 01/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2021
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022 - 01/2020
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2008
3	MorpholinosIBA 12/2019 - 01/2017
3	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2019 - 11/2010
3	MelatoninIBA 01/2019 - 10/2011
3	IronIBA 01/2019 - 10/2012
3	CD40 Ligand (CD40L)IBA 01/2018 - 06/2005
3	Therapeutic UsesIBA 10/2017 - 02/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 09/2009
2	seladelparIBA 02/2024 - 01/2023
2	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2021
2	Intrinsic Factor FDA Link 06/2023 - 03/2019
2	setanaxibIBA 01/2023 - 01/2023
2	Transaminases (Aminotransferases)IBA 01/2023 - 12/2016
2	Alanine Transaminase (SGPT)IBA 12/2022 - 01/2017
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2022
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 09/2022 - 01/2021
2	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2022 - 09/2021
2	AvidinIBA 01/2022 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2019
2	Nucleic AcidsIBA 01/2022 - 01/2019
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 12/2016
2	Fibric Acids (Fibrates)IBA 01/2021 - 11/2020
2	Serum AlbuminIBA 11/2020 - 01/2018
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2020 - 01/2019
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2020 - 06/2008

Therapy/Procedure

40	Therapeutics 01/2024 - 11/2010
17	Liver Transplantation 11/2023 - 06/2008
7	Precision Medicine 01/2023 - 08/2016
4	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
3	Artificial Respiration (Mechanical Ventilation) 10/2022 - 01/2021
3	Transplantation 05/2022 - 02/2018
3	Aftercare (After-Treatment) 01/2020 - 05/2011
2	Biological Therapy 01/2023 - 09/2021
2	Contraindications 01/2023 - 02/2018
2	Cannula 10/2022 - 01/2022